Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | NC410 |
Trade Name | |
Synonyms | NC-410|NC 410 |
Drug Descriptions |
NC410 is a dimeric Lair2 fusion protein that binds collagen and inhibits its interaction with Lair1, resulting in decreased Lair1 downstream signaling and potentially leading to enhanced antitumor immune response and inhibition of tumor growth (PMID: 34121658). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C173559 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
NC410 | NC410 | 0 | 1 |
NC410 + Pembrolizumab | NC410 Pembrolizumab | 0 | 1 |